Nitroaspirin Corrects Immune Dysfunction in Tumor-Bearing Hosts and Promotes Tumor Eradication by Cancer Vaccination - De Santo, Carmela; Serafini, Paolo; Marigo, Ilaria; Dolcetti, Luigi; Bolla, Manlio; Del Soldato, Piero; Melani, Cecilia; Guiducci, Cristiana; Colombo, Mario P.; Iezzi, Manuela; Musiani, Piero; Zanovello, Paola; et al. (Proceedings of the National Academy of Sciences - PNAS, 2005)
Keywords: Amino acids; Animals; Anti-Inflammatory Agents, Non-Steroidal - pharmacology; Aspirin - analogs & derivatives; Aspirin - pharmacology; Biological Sciences; Cancer; Cancer Vaccines - pharmacology; Carrier Proteins; Cell lines; Clinical trials; Enzymatic activity; Enzymes; Immune status; Immune system; Immune System Diseases - drug therapy; Immune System Diseases - immunology; Lipocalins; Lymphocytes; Mice; Mice, Inbred BALB C; Molecules; Myeloid cells; Neoplasm Proteins; Neoplasms - drug therapy; Neoplasms - immunology; Neoplasms - mortality; Nitric oxide; Nitric Oxide Synthase - metabolism; Pharmacology; Splenocytes; T lymphocytes; T-Lymphocytes - drug effects; T-Lymphocytes - immunology; Time Factors; Tumor cell line; Tumors; Vaccination; Vaccines